This segment encompasses the core business of Siloam International Hospitals, focusing on providing comprehensive medical services through its network of hospitals. This includes general and specialist medical care, encompassing areas such as pediatrics, neurosciences, cardiology, oncology, and surgery. The hospitals are equipped with advanced medical technologies for diagnostics, imaging, and treatment. Research and development activities within this segment focus on improving patient outcomes and operational efficiency. This includes the implementation of advanced medical technologies, such as AI-powered diagnostics and surgical robotics. The segment's market positioning is strong due to its extensive network and comprehensive service offerings, providing a competitive advantage in the Indonesian healthcare market. Future opportunities include expansion of services, adoption of new technologies, and strategic partnerships to enhance patient care and market reach. Regulatory compliance and patient safety are paramount, with adherence to Indonesian healthcare regulations and international standards.

This segment focuses on providing advanced diagnostic and imaging services to support accurate and timely medical diagnoses. Siloam Hospitals utilizes state-of-the-art technologies, including MRI, CT scans, X-rays, ultrasound, and laboratory services. Research and development efforts are focused on improving the accuracy and efficiency of diagnostic procedures, including the integration of AI for image analysis and interpretation. The segment's market positioning is enhanced by its investment in cutting-edge technology and its ability to provide rapid and reliable diagnostic results. This segment directly impacts patient outcomes by enabling early and accurate diagnoses, leading to more effective treatment plans. Future opportunities include expanding the range of diagnostic services, integrating telemedicine for remote consultations, and leveraging data analytics to improve patient care pathways. The segment adheres to strict regulatory standards for medical imaging and laboratory testing, ensuring patient safety and data integrity. Partnerships with technology providers and research institutions are crucial for staying at the forefront of diagnostic innovation.

This segment encompasses specialized medical services, including complex surgical procedures, oncology treatments, cardiology interventions, and other advanced medical care. Siloam Hospitals provides specialized care in areas such as cardiology, oncology, neurology, and orthopedics. Research and development activities focus on improving treatment outcomes and developing innovative therapies. This includes clinical trials, the adoption of advanced surgical techniques, and the integration of precision medicine approaches. The segment's market positioning is enhanced by its ability to offer specialized care and attract highly skilled medical professionals. This segment directly impacts patient outcomes by providing access to advanced treatments and improving the quality of life for patients with complex medical conditions. Future opportunities include expanding the range of specialized services, investing in advanced medical technologies, and developing partnerships with leading medical institutions. The segment adheres to stringent regulatory requirements for specialized medical procedures and treatments, ensuring patient safety and efficacy. Collaborations with pharmaceutical companies and medical device manufacturers are essential for accessing the latest therapies and technologies.